March 19 (Reuters) - Theravance Biopharma ( TBPH ) Q4 adjusted
net income USD 3.131 million
* Q4 net income USD 61.024 million
* Q4 revenue USD 45.9 million vs. IBES estimate USD 58.5
million
* Q4 EPS USD 1.15